Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Affymetrix, Inc.
Coriell Institute for Medical Research Selects Affymetrix DMET Plus Product for National Personalized Medicine Project
January 30th, 2009
Affymetrix, Inc. (Nasdaq:AFFX) announced that the Coriell Personalized Medicine Collaborative (CPMC), part of the Coriell Institute for Medical Research, has selected its new DMET Plus Product for a national project to identify biologically relevant markers for drug response. Since the DMET Plus Product was launched last November, five additional organizations have adopted it to support studies investigating the relationship between genes and drug metabolism and 18 are scheduled to be trained. Launched in December 2007, the CPMC has been using the Genome-Wide Human SNP Array 6.0 to identify genes associated with complex health conditions, such as cancer, heart and blood...
Source: Health Business Week (2009-01-30)
|
